Navigation Links
Side-Out Foundation teams with leading medical professionals to battle breast cancer
Date:10/22/2009

Fairfax, VA. (Oct. 22, 2009) -- The Side-Out Foundation and its Dig Pink Volleyball Breast Cancer Awareness campaign will launch a first of its kind clinical trial this month to examine the effects of individualized treatment on patients with metastatic breast cancer. Individualized treatment, known as targeted therapy, provides doctors a better way to tailor cancer treatment and offers the hope of more precisely targeting the cancerous cells, which would reduce side effects and improve quality of life.

The trial protocol will bring together the diverse skills and unique experience of community oncologists, nurses and researchers in the field molecular medicine. Clinical trials will occur at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare and Fairfax Northern Virginia Hematology Oncology. TGen Drug Development Services (TD2) will manage the trial for the Side-Out Foundation. The two major contributing laboratories are CARIS Diagnostics, and George Mason University's Center for Applied Proteomics and Molecular Medicine.

This pilot study follows on the heels of the Bisgrove Trial, which indicated cancer patients can survive longer under treatments based on their individual genetic profiles. Results were reported in April 2009 by TCRS at Scottsdale Healthcare in connection with Caris Dx.

While the Bisgrove Trial was a broader-based solid tumor cancer study, the results of this study indicated the potential clinical benefit of a molecular-based personalized therapy selection strategy for patients with recurrent and/or metastatic disease. Intended to provide real time treatment recommendations to physicians, this metastatic breast cancer trial will be conducted over the next 24 months.

Researchers will utilize these advanced molecular profiling technologies, focusing on tailoring therapy for each patient based on the individual genomic and proteomic molecular portrait within the metastatic lesion itself. The patient would then be treated with a single agent based on the aggregate information provided by the genomic and proteomic molecular profiling analyses.

High schools and colleges across the country will host volleyball matches to "pink-out" the stands this October, Breast Cancer Awareness month, in support of this new research.

The Side-Out Foundation is continuing that momentum by attracting more than 1,000 additional high schools and colleges to compete in similar volleyball tournaments in order to raise $1,000,000 in support of breast cancer research and the social and physiological aspects of the disease .


'/>"/>

Contact: Keith Jones
kjones@shc.org
Scottsdale Healthcare
Source:Eurekalert

Related medicine news :

1. Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation on the Launch of the State of the World's Vaccines and Immunization Report
2. Bill & Melinda Gates Foundation Funds 76 New Ideas to Improve Global Health, From Chewing Gum to Chocolate
3. Bill & Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious Disease
4. Robert Wood Johnson Foundation, The Pew Charitable Trusts Launch National Initiative to Advance Policies That Promote Health
5. Karmanos Cancer Institute Receives $3 Million Grant from The Herrick Foundation to Launch Challenge Initiative for Cancer Research
6. Hospice Foundation of America Presents Webinar on Grief, Holidays, and Family Dynamics
7. The Regence Foundation Announces Debut of Sojourns Award for Innovation and Leadership in Palliative Care
8. HealthWell Foundation(R) Appoints New Executive Director
9. Philips Healthcare CEO Joins Focused Ultrasound Surgery Foundation Board of Directors
10. Photos: Avon Foundation for Women Celebrates Breast Cancer Awareness Month
11. Univision and Kaiser Foundation Mark National Latino AIDS Awareness Day With New Campaign Featuring People Living With HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... Orange County dentist, ... inflammatory gum condition that occurs when the bacteria in plaque infect the gums and ... as a scaling and root planing or SRP, and can include surgical therapies if ...
(Date:2/27/2017)... ... February 27, 2017 , ... Texas based retail ... addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds 150,000. , ... had 800 customers and 2,250 RCEs at the time of acquisition. In the ...
(Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among ... all types and genders. And the need for advanced services is growing. , ... top-rated cancer care program, in collaboration with their non-profit partners in their fight against ...
(Date:2/26/2017)... Mateo, CA (PRWEB) , ... February 26, 2017 , ... ... Area cities as diverse as Millbrae, Belmont, and Palo Alto, is proud to announce ... Mateo. Many Bay Area consumers look for home care close to home, and by ...
(Date:2/26/2017)... ARLINGTON, VA (PRWEB) , ... February 26, 2017 , ... ... Medicaid Managed Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, ... work with PerformCARE to use behavioral health analytics to improve Medicaid population health management. ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Israel and TAMPA, Fla. , Feb. ... emerging medical device company focused on developing cerebral ... applauds the members of the FDA,s Circulatory System ... their acknowledgement of the need for cerebral protection ... "The statements shared by this FDA panel ...
(Date:2/27/2017)... Feb. 27, 2017  Impax Laboratories, Inc. (NASDAQ: IPXL ) today ... Raymond James and Associates, 38 th ... 2017 in Orlando, FL. Cowen ... ET on March 7, 2017 in Boston, MA. ... 16, 2017 in Miami, FL. ...
(Date:2/27/2017)... 27, 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and ... , M.D., Ph.D., as President and Chief Executive Officer (CEO) ... 2017. Dr. Craig succeeds Richard Love , interim President ... Board of Directors.  Dr. Craig has over 20 years of ... US and Europe . "On ...
Breaking Medicine Technology: